Stockscreener 앱 받기
25.72
1.70%
0.43
시간 외 거래:
25.72
전일 마감가:
$25.29
열려 있는:
$25.24
하루 거래량:
898.33K
Relative Volume:
1.00
시가총액:
$11.21B
수익:
$5.64B
순이익/손실:
$305.00M
주가수익비율:
36.85
EPS:
0.698
순현금흐름:
-
1주 성능:
+7.66%
1개월 성능:
+4.30%
6개월 성능:
-9.08%
1년 성능:
-8.70%
1일 변동 폭
$25.24
$25.72
1주일 범위
$24.35
$27.10
52주 변동 폭
$23.65
$31.72
Smith Nephew Plc Adr Stock (SNN) Company Profile
SNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
25.72 | 11.21B | 5.64B | 305.00M | 0 | 0.698 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-06 | 다운그레이드 | Berenberg | Buy → Hold |
| 2024-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-07-24 | 개시 | Deutsche Bank | Buy |
| 2024-06-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-11-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2023-11-03 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-10-31 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2023-10-13 | 개시 | Stifel | Hold |
| 2023-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2023-04-27 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-04-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | 개시 | Citigroup | Buy |
| 2022-11-28 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-07-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-15 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-04 | 업그레이드 | Redburn | Sell → Neutral |
| 2021-06-09 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | 개시 | Barclays | Overweight |
| 2020-07-29 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-11-21 | 개시 | Citigroup | Buy |
| 2019-11-12 | 개시 | Bernstein | Outperform |
| 2019-07-23 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-02-08 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-12-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | 재확인 | Canaccord Genuity | Buy |
| 2018-01-25 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | 개시 | Canaccord Genuity | Buy |
| 2017-02-27 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-01-19 | 개시 | HSBC Securities | Hold |
| 2016-12-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | 다운그레이드 | Berenberg | Buy → Hold |
| 2016-02-26 | 개시 | Cantor Fitzgerald | Hold |
모두보기
Smith Nephew Plc Adr 주식(SNN)의 최신 뉴스
Pressure Ulcer Device Market is Projected to Grow at a 5.6% CAGR, Reaching US$ 9,380.8 Million by 2034 | Fact.MR Report - GlobeNewswire Inc.
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Smith & Nephew Earnings: Quarterly Sales Suggest China Weakness Into 2025 - Morningstar
Smith & Nephew Sees Challenges in China Market - Morningstar
Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device
Analytical Overview: Smith & Nephew plc ADR (SNN)’s Ratios Tell a Financial Story - The Dwinnex
Smith+Nephew launches new Legion knee system - Mass Device
South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew Aligns Director Fees with Shares - TipRanks
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Smith+Nephew announces first Catalystem hip system procedures - Mass Device
Ratios in Focus: Analyzing Smith & Nephew plc ADR (SNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Smith+Nephew launches Total Ankle patient-matched guides - Mass Device
Upward Trajectory: Smith & Nephew plc ADR (SNN) Posts a Slidee, Closing at 30.67 - The Dwinnex
Saudi Arabia Antimicrobial Wound Care Dressings Market Size & Outlook, 2030 - Grand View Research
Medical Robotics Surgery Market to Grow at CAGR of 10.82% through 2033 - GlobeNewswire Inc.
InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device
Smith & Nephew plc ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
Kyphoplasty Market Research 2024 - GlobeNewswire Inc.
Smith+Nephew shares jump on strong H1 results and reaffirmed guidance - Investing.com
Global Alginate Dressing Market worth $1,129.4 million by - GlobeNewswire Inc.
Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device
Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha
Smith & Nephew shares surge as Cevian takes stake in medical devices group - Investing.com
Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device
Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance
Smith+Nephew rolls out new chronic wound treatment tech - Mass Device
7 Robotic Surgery Stocks to Buy for the Future of Healthcare - Yahoo Finance
Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device
Smith+Nephew kicks off Aetos shoulder system launch at AAOS - Mass Device
Smith+Nephew unveils expanded sports medicine portfolio - Mass Device
Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device
Smith+Nephew launches hip arthroplasty system in India - Mass Device
Smith+Nephew CFO to step down, revenue guidance increased - Mass Device
Smith+Nephew wins FDA clearance for shoulder replacement system - Mass Device
SNN: Add This Top Equipment Stock to Your Portfolio for a Strong Week Ahead - StockNews.com
Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device
Zimmer Biomet Holdings Inc. stock falls Thursday, underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock outperforms market despite losses on the day - MarketWatch
8 Newly Undervalued 5-Star Stocks - Morningstar
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Smith Nephew Plc Adr (SNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.55%
자본화:
|
볼륨(24시간):